Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Bvf Partners L P/il
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
4d Molecular Therapeutics, Inc.
Adolor Corp.
Aerogen Inc
Allakos Inc.
ArQule Inc.
Array BioPharma, Inc.
Avigen Inc.
Calithera Biosciences, Inc.
Celera Corp
Cell Therapeutics, Inc.
ChemoCentryx, Inc.
Concert Pharmaceuticals, Inc.
Cullinan Therapeutics, Inc.
Curis Inc.
Cytokinetics Inc.
Cytomx Therapeutics, Inc.
Dynavax Technologies Corp.
Eledon Pharmaceuticals, Inc.
Engene Holdings Inc.
Epirus Biopharmaceuticals, Inc.
Essa Pharma Inc.
Facet Biotech Corp
Five Prime Therapeutics, Inc.
Glycomimetics Inc
ICAgen Inc.
Ideaya Biosciences, Inc.
Immune Design Corp.
Infinity Pharmaceuticals, Inc.
Inhibitex Inc.
Kent International Holdings Inc.
Kymera Therapeutics, Inc.
Ligand Pharmaceuticals Inc.
MediciNova Inc.
Merus N.V.
Moonlake Immunotherapeutics
Neurobiological Technologies Inc.
Neurocrine Biosciences Inc.
Neurogen Corp.
Nivalis Therapeutics, Inc.
NPS Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc.
Oncothyreon Inc
Orthologic Corp.
Palatin Technologies Inc.
Pharmacopeia, Inc.
Pieris Pharmaceuticals, Inc.
Point Biopharma Global Inc.
Principia Biopharma Inc.
Rain Oncology Inc.
Regulus Therapeutics Inc.
Repare Therapeutics Inc.
Repligen Corp.
Repros Therapeutics Inc.
Rigel Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc.
Structure Therapeutics Inc.
SuperGen Inc.
Syndax Pharmaceuticals Inc
Targacept, Inc.
Third Harmonic Bio, Inc.
Tobira Therapeutics, Inc.
Verastem, Inc.
Viacell Inc
Xenon Pharmaceuticals Inc.
XOMA Ltd.
Ligand Pharmaceuticals Inc.
Avg. Two Year Performance
215%
Avg. Purchase Return
78%
Compound
(52%)
Avg. Sale Return
(23%)
Compound
Holdings:
360.3K
shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Drug Manufacturers - Other
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
